Study Using Dexmedetomidine to Decreases Emergence Delirium in Pediatric Patients

• Status: Unknown status
• Trial end date: 2015-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the use of intranasal dexmedetomidine to reduce the incidence of emergence delirium during general sevoflurane anesthesia in a pediatric population receiving pressure equalization tubes in one or more ear.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Ochsner Health System
• Treatments: Dexmedetomidine; Sevoflurane

Criteria

Inclusion Criteria:

• ASA class 1 or 2 (healthy patient or acute illness)

• Parental willingness to participate

• Candidate for pressure-equalization tubes (PET) as determined by the ENT department

Exclusion Criteria:

• ASA class 3 or 4 (chronic illness or life-threatening illness)

• Parental refusal to participate

• Significant liver disease by history

• Allergy to dexmedetomidine or midazolam

• Nasal deformity

• Fever in the three days prior to surgery

• Nausea or vomiting

• History of hypertension

• History of cardiac dysfunction/disorder

• Diabetes mellitus